Skip to main content
×
Home
    • Aa
    • Aa

Appropriate prescribing in older people

  • Justin Penge (a1) and Peter Crome (a2)
Abstract
Summary

Prescribing for older people is often complex and challenging. With age, people almost invariably develop diseases leading to the prescription of drugs and the risk of multiple prescribing increases, especially if there is strict adherence to single disease guidelines. There remains a paucity of evidence from clinical trials as to the efficacy of many drugs in patients aged over 80 years due to the gross under-representation of older people in clinical trials. Older people are also at increased risk of adverse drug events, which are an important cause of morbidity and mortality. A significant percentage of these are both predictable and potentially avoidable.

In this updated review the concept of appropriate prescribing in older people is explored, including the importance of individualized care and shared decision-making. The available tools to enhance prescribing practice are examined, including those aimed at reducing inappropriate prescriptions and under prescribing. The limitations of existing tools are discussed and areas with particular promise and scope for advancement are highlighted, including the development of integrated IT systems and software engines to aid clinicians in appropriate prescribing.

Copyright
Corresponding author
Address for correspondence: Justin Penge, Royal Free Hospital, Pond Street, London NW3 2QG. Email: justinpenge@nhs.net
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1 JH Gurwitz , TS Field , J Avorn et al.Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000; 109: 8794.

2 JT Hanlon , KE Schmader , CM Ruby , M Weinberger . Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 2001; 49: 200–9.

4 DW Habicht , MD Witham , MET McMurdo . The under-representation of older people in clinical trials: Barriers and potential solutions. J Nutr Health Aging 2008; 12: 194–96.

9 PA Routledge , MS O'Mahony , KW Woodhouse . Adverse drug reactions in elderly patients. Br J Clin Pharmacol 2004; 57: 121–26.

10 M Franceschi , C Scarcelli , V Niro et al.Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients. Drug Saf 2008; 31: 545–56.

11 I Mukhopadhyay , F Lally , P Crome . Appropriate prescribing in older people. Rev Clin Gerontol 2007; 17: 139–51.

12 PA Parish . Drug prescribing – the concern of all. R Soc Health J 1973; 93: 213–17.

13 M Somel , P Khaitovich , S Bahn , S Paabo , M Lachmann . Gene-expression becomes heterogenous with age. Curr Biol 2006; 16: R35960.

14 EA Nelson , D Dannefer . Aged heterogeneity: fact or fiction? The fate of diversity in gerontological research. Gerontologist 1992; 32: 1723.

16 SHD Jackson , AA Mangoni , GM Batty . Optimization of drug prescribing. Br J Clin Pharmacol 2004; 57: 231–36.

17The American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatric Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc 2012; 60: 616–31.

18 N Barber . What constitutes good prescribing? BMJ 1995; 310: 923–25.

19 EAG Joosten , L DeFuentes-Merillas , GH de Weert , T Sensky , CPF van der Staak , CAJ de Jong . Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychother Psychosom 2008; 77: 219–26.

21 JH Lewis , ML Kilgore , DP Goldman et al.Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 2003; 21: 1383–89.

22 LF Hutchins , JM Unger , JJ Crowley , CA Coltman , KS Albain . Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999; 341: 2061–67.

23 JG Ford , MW Howerton , GY Lai et al.Barriers to recruiting underrepresented populations to cancer clinical trials: A systematic review. Cancer 2008; 112: 228–42.

24 MW Rich , MS Bosner , MK Chung , J Shen , JP McKenzie . Is age an independent predictor of early and late mortality in patients with acute myocardial infarction? Am J Med 1992; 92: 713.

25 PY Lee , KP Alexander , BG Hammill , SK Pasquali , ED Peterson . Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 2001; 286: 708–13.

26 FA Masoudi , EP Havranek , P Wolfe et al.Most hospitalized older persons do not meet the enrolment criteria for clinical trials in heart failure. Am Heart J 2003; 146: 250–57.

28 BD Smith , GL Smith , A Hurria , GN Hortobagyi , TA Buchholz . Future of cancer incidence in the United States: Burdens upon an aging, changing nation. J Clin Oncol 2009; 27: 2758–65.

29 JM Unger , CA Coltman , JJ Crowley et al.Impact of the year 2000 Medicare policy change on older patient enrolment to cancer clinical trials. J Clin Oncol 2006; 24: 141–44.

30The IST-3 collaborative group. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 2012; 379: 2352–63.

31 A Cherubini , S Del Signore , J Ouslander , T Semla , JP Michel . Fighting against age discrimination in clinical trials. J Am Geriatr Soc 2010; 58: 1791–96.

34 S Thomson , P Crome . Appropriate prescribing in older people. Rev Clin Gerontol 2002; 12: 213–20.

35 T Kairuz , L Bye , R Birdsall et al.Identifying compliance issues with prescription medicines among older people: a pilot study. Drugs Aging 2008; 25: 153–62.

36 E Burns , CA Austin , NDS Bax . Elderly patients’ understanding of their drug therapy: the effect of cognitive function. Age Ageing 1990; 19: 236–40.

37 J Nunney , DK Raynor , P Knapp , SJ Closs . How do the attitudes and beliefs of older people and healthcare professionals impact on the use of multi-compartment compliance aids? Drugs Aging 2011; 28: 403–14.

40 MH Chin , LC Wang , L Jin et al.Appropriateness of medication selection for older persons in an urban academic emergency department. Acad Emerg Med 1999; 6: 1232–41.

41 CM Lindley , MP Tully , V Paramsothy , RC Tallis . Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992; 21: 294300.

42 MH Beers , JG Ouslander , SF Fingold et al.Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med 1992; 117: 684–89.

43 MH Beers , JG Ouslander , I Rollinger , DB Reuben , J Brooks , JC Beck . Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991; 151: 1825–32.

44 D Opondo , S Eslami , S Visscher , SE de Rooij , R Verheij et al.Inappropriateness of medication prescriptions to elderly patients in the primary care setting: a systematic review. PLoS ONE 2012; 7: e43617. doi:10.1371/journal.pone.0043617

45 MR Goulding . Inappropriate medication prescribing for elderly ambulatory-care patients. Arch Intern Med 2004; 164: 305–12.

46 AE Stuck , MH Beers , A Steiner , HU Aronow , LZ Rubenstein , JC Beck . Inappropriate medication use in community-residing older persons. Arch Intern Med 1994; 154: 2195–200.

47 C Zhan , J Sangl , AS Bierman et al.Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. JAMA 2001; 286: 2823–29.

48 MS Giron , HX Wang , C Bernsten , M Thorslund , B Winblad , J Fastbom . The appropriateness of drug use in an older non-demented and demented population. J Am Geriatr Soc 2001; 49: 277–83.

49 P Gallagher , D O'Mahony . STOPP (Screening Tool of Older Persons’ potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers’ criteria. Age Ageing 2008; 37: 673–79.

50 CM Boyd , J Darer , C Boult , LP Frier , L Boult , AW Wu . Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005; 294: 716–24.

51 A Kennerfalk , A Ruigomez , MA Wallander , L Wilhelmsen , S Johansson . Geriatric drug therapy and healthcare utilization in the United Kingdom. Ann Pharmacother 2002; 36: 797803.

52 C Naughton , K Bennett , J Feely . Prevalence of chronic disease in the elderly based on a national pharmacy claims database. Age Ageing 2006; 35: 633–36.

53 D Garfinkel , D Mangin . Feasibility study of a systematic approach for discontinuation of multiple medications in older patients. Arch Intern Med 2010; 170: 1648–54.

54 PA Rochon , JH Gurwitz . Optimising drug treatment for elderly people: the prescribing cascade. BMJ 1997; 315: 1096–99.

56 V Rollason , N Vogt . Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging 2003; 20: 817–32.

57 RK Schwartz , SB Soumerai , J Avorn . Physician motivations for non-scientific drug prescribing. Soc Sci Med 1989; 28: 577–82.

58 A Zarba , CL Storr , FA Wagner . Carrying habits into old age: prescription drug use without medical advice by older American adults. J Am Geriatr Soc 2005; 53: 170–71.

59 SW Lai , KF Liao , CC Liao , CH Muo , CS Liu , FC Sung . Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study. Medicine 2010; 89: 295–99.

60 ER Hajjar , AC Cafiero , JT Hanlon . Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007; 5: 345–51.

61 PJ Barry , P Gallagher , C Ryan , D O'Mahony . START (Screening Tool to Alert doctors to Right Treatment) – an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing 2007; 36: 632–38.

63 SB Soumerai , TJ McLaughlin , D Spiegelman , E Hertzmark , G Thibault , L Goldman . Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA 1997: 277: 115–21.

64 MH Chin , JC Wang , JX Zhang , RM Lang . Utilization and dosing of angiotensin-converting enzyme inhibitors for heart failure. J Gen Intern Med 1997; 12: 563–66.

66 G Mendelson , WS Aronow . Underutilization of angiotensin-converting enzyme inhibitors in older patients with Q-wave anterior myocardial infarction in an academic hospital-based geriatrics practice. J Am Geriatr Soc 1998; 46: 751–52.

67 A Cherubini , A Corsonello , F Lattanzio . Underprescription of beneficial medicines in older people: causes, consequences and prevention. Drugs Aging 2012; 29: 463–75.

68 MAJ Kuijpers , RJ van Marum , ACG Egberts , PAF Jansen . Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol 2008; 65: 130–33.

70 MH Beers . Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997; 157: 1531–36.

71 DM Fick , JW Cooper , WE Wade , JL Waller , JR Maclean , MH Beers . Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163: 2716–24.

72 P Gallagher , C Ryan , S Byrne , J Kennedy , D O'Mahony . STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008; 46: 7283.

73 H Hamilton , P Gallagher , C Ryan , S Byrne , D O'Mahony . Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med 2011; 171: 1013–19.

77 JT Hanlon , KE Schmader , GP Samsa et al.A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992; 45: 1045–51.

78 NS Wenger , PG Shekelle . Assessing care of vulnerable elders: ACOVE Project Overview. Ann Intern Med 2001; 135: 642–46.

79 MP Tully , JA Cantrill . The validity of explicit indicators of prescribing appropriateness. Int J Qual Health Care 2006; 18: 8794.

80 G Onder , F Landi , R Liperoti , D Fialova , G Gambassi , R Bernabei . Impact of appropriate drug use among hospitalized older adults. Eur J Clin Pharmacol 2005; 61: 453–59.

81 ML Laroche , JP Charmes , Y Nouaille , N Picard , L Merle . Is inappropriate medication use a major cause of adverse drug reactions in the elderly? Br J Clin Pharmacol 2007; 63: 177–86.

82 DS Budnitz , N Shehab , SR Kegler , CL Richards . Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med 2007; 147: 755–65.

83 A Spinewine , C Swine , S Dhillon et al.Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomized, controlled trial. J Am Geriatr Soc 2007; 55: 658–65.

84 ML Laroche , JP Charmes , L Merle . Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol 2007; 63: 725–31.

85 EL Knight , J Avorn . Quality indicators for appropriate medication use in vulnerable elders. Ann Intern Med 2001; 135: 703–10.

86 NS Wenger , CP Roth , P Shekelle , ACOVE Investigators. Introduction to the assessing care of vulnerable elders – 3 quality indicator measurement set. J Am Geriatr Soc 2007; 55 (suppl 2): S24752.

88 R Kassam , LG Martin , KB Farris . Reliability of a modified medication appropriateness index in community pharmacies. Ann Pharmacother 2003; 37: 4046.

89 JA Cantrill , B Sibbald , S Buetow . Indicators of the appropriateness of long-term prescribing in general practice in the United Kingdom: consensus development, face and content validity, feasibility and reliability. Qual Saf Health Care 1998; 7: 130–35.

92 SA Buetow , B Sibbald , JA Cantrill , S Halliwell . Appropriateness in health care: application to prescribing. Soc Sci Med 1997; 45: 261–71.

93 CA Oborne , GM Batty , V Maskrey , CG Swift , SH Jackson . Development of prescribing indicators for elderly medical inpatients. Br J Clin Pharmacol 1997; 43: 9197.

94 RL Grant , GM Batty , R Aggarwal et al.National sentinel clinical audit of evidence-based prescribing for older people: methodology and development. J Eval Clin Pract 2002; 8: 189–98.

95 D O'Mahony , MN O'Connor . Pharmacotherapy at the end-of-life. Age Ageing 2011; 40: 419–22.

96 AR Maddison , J Fisher , G Johnston . Preventive medication use among persons with limited life expectancy. Prog Palliat Care 2011; 19: 1521.

97 JE Hardy , SN Hilmer . Deprescribing in the last year of life. J Pharm Pract Res 2011; 41: 146–51.

98 DC Currow , JP Stevenson , AP Abernethy , J Plummer , TM Shelby-James . Prescribing in palliative care as death approaches. J Am Geriatr Soc 2007; 55: 590–95.

99 C Faull , K Windridge , E Ockleford , M Hudson . Anticipatory prescribing in terminal care at home: what challenges do community health professionals encounter? BMJ Support Palliat Care 2013; 3: 9197.

100 MA Steinman , CS Landefeld , GE Rosenthal , D Berthenthal , S Sen , PJ Kaboli . Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 2006; 54: 1516–23.

101 WH Shrank , JM Polinski , J Avorn . Quality indicators for medication – use in vulnerable elders. J Am Geriatr Soc 2007; 55: S37382.

104 DS Budnitz , MC Lovegrove , N Shehab , CL Richards . Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 2011; 365: 2002–12.

105 J Ansell , J Hirsh , E Hylek , A Jacobsen , M Crowther , G Palareti . Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edn). Chest 2008;133 (suppl 6): 160–98S.

108 M Crotty , J Halbert , D Rowett et al.An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing. Age Ageing 2004; 33: 612–17.

109 JYF Wu , WYS Leung , S Chang et al.Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial. BMJ 2006; 333: 522–28.

110 M Monane , DM Matthias , BA Nagle , MA Kelly . Improving prescribing patterns for the elderly through an online drug utilization review intervention: a system linking the physician, pharmacist, and computer. JAMA 1998; 280: 1249–52.

111 JM Teich , PR Merchia , JL Schmitz , GJ Kuperman , CD Spurr , DW Bates . Effects of computerized physician order entry on prescribing practices. Arch Intern Med 2000; 160: 2741–47.

112 DW Bates , LL Leape , DJ Cullen et al.Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998; 280: 1311–16.

113 DW Bates . Using information technology to reduce rates of medication errors in hospitals. BMJ 2000; 320: 788–91.

114 GJ Kuperman , A Bobb , TH Payne et al.Medication-related clinical decision support in computerized provider order entry systems: a review. J Am Med Inform Assoc 2007; 14: 2940.

116 E Charani , Y Kyratsis , W Lawson et al.An analysis of the development and implementation of a smartphone application for the delivery of antimicrobial prescribing policy: lessons learnt. J Antimicrob Chemother 2013; 68: 960–67.

117 L Dayer , S Heldenbrand , P Anderson , PO Gubbins , BC Martin . Smartphone medication adherence apps: potential benefits to patients and providers. J Am Pharm Assoc 2013; 53: 172–81.

118 F Haffey , RRW Brady , S Maxwell . A comparison of the reliability of smartphone apps for opioid conversion. Drug Safety 2013; 36: 111–17.

119 AL Hume , BJ Quilliam , R Goldman , C Eaton , KL Lapane . Alternatives to potentially inappropriate medications for use in e-prescribing software: triggers and treatment algorithms. BMJ Qual Saf 2011; 20: 875–84.

121 H Merten , M Zegers , MC de Bruijne , C Wagner . Scale, nature, preventability and causes of adverse events in hospitalised older patients. Age Ageing 2013; 42: 8793.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Reviews in Clinical Gerontology
  • ISSN: 0959-2598
  • EISSN: 1469-9036
  • URL: /core/journals/reviews-in-clinical-gerontology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords: